Apogee Therapeutics, Inc (APGE) insider trading
Every open-market stock purchase and sale by Apogee Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $15M over the last 12 months (1 buy).
- Insiders sold $170M over the last 12 months (32 sales).
- Last insider buy: Nimish P Shah (Insider), $15M, 12 months ago.
Last 12 months: insiders bought $15M (1 buy) and sold $170M (32 sales). Last close $86.92 on Jun 4, 2026.
Recent APGE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | Michael Thomas Henderson (CEO) | Sold | $10.6M |
| Jun 22, 2026 | Carl Dambkowski (C-suite exec) | Sold | $3.5M |
| Jun 10, 2026 | Michael Thomas Henderson (CEO) | Sold | $634K |
| Jun 10, 2026 | Michael Thomas Henderson (CEO) | Sold | $557K |
| Jun 10, 2026 | Michael Thomas Henderson (CEO) | Sold | $199K |
| Jun 10, 2026 | Michael Thomas Henderson (CEO) | Sold | $134K |
| Jun 10, 2026 | Michael Thomas Henderson (CEO) | Sold | $90.9K |
| Jun 10, 2026 | Michael Thomas Henderson (CEO) | Sold | $53.4K |
| Jun 9, 2026 | Fairmount Funds Management LLC (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Lisa Bollinger (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Jennifer A. Fox (Director) | Bought (not open market) | — |
| Jun 9, 2026 | William A Jones Jr (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Mark C. McKenna (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Nimish P Shah (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Carl Dambkowski (C-suite exec) | Sold | $433K |
| Jun 3, 2026 | Carl Dambkowski (C-suite exec) | Bought (not open market) | — |
| May 13, 2026 | Michael Thomas Henderson (CEO) | Sold | $1.5M |
| May 13, 2026 | Michael Thomas Henderson (CEO) | Sold | $111K |
| May 6, 2026 | Carl Dambkowski (C-suite exec) | Sold | $311K |
| May 6, 2026 | Carl Dambkowski (C-suite exec) | Sold | $152K |
| May 6, 2026 | Carl Dambkowski (C-suite exec) | Bought (not open market) | — |
| May 1, 2026 | Jane Henderson (CFO) | Sold | $74.3K |
| May 1, 2026 | Jane Henderson (CFO) | Sold | $65.7K |
| May 1, 2026 | Jane Henderson (CFO) | Sold | $24K |
| Apr 16, 2026 | Jane Henderson (CFO) | Sold | $180K |
Who's trading APGE
- Carl Dambkowski, C-suite exec: sold $8.5M (24 sales), last Jun 22, 2026
- Michael Thomas Henderson, CEO: sold $25.7M (32 sales), last Jun 22, 2026
- Jennifer A. Fox, Director: other filings, last Jun 9, 2026
- Nimish P Shah, Director: bought $15M (1 buy), last Jun 9, 2026
- Fairmount Funds Management LLC, Director: sold $134M (1 sale), last Jun 9, 2026
- Mark C. McKenna, Director: other filings, last Jun 9, 2026
- Lisa Bollinger, Director: other filings, last Jun 9, 2026
- William A Jones Jr, Director: other filings, last Jun 9, 2026
- Jane Henderson, CFO: sold $2.1M (21 sales), last May 1, 2026
Get free alerts when an insider at Apogee Therapeutics, Inc files a new trade →